Author
|
Country
|
Year
|
Design
|
No of patients
|
Age
|
TSB(μmol/l)
|
Sex (M/F)
|
BMI
|
Bismuth-classification
|
---|
NPBD
|
PBD
|
NPBD
|
PBD
|
NPBD
|
PBD
|
NPBD
|
PND
|
NPBD
|
PBD
|
NPBD
|
PBD
|
---|
Cai et al. [21]
|
CN
|
2017
|
RETRO
|
163
|
55
|
60 ± 9
|
59 ± 11
|
161.0 (8.4–455.6)
|
281.1 (8.2–565.4)
|
74/89
|
30/25
|
22.5 ± 6.8
|
21.8 ± 5.9
|
24/28/24/42/45
|
9/13/10/8/5
|
Kennedy et al. [22]
|
USA
|
2009
|
RETRO
|
29
|
31
|
NR
|
NR
|
NR
|
NR
|
NR
|
NR
|
NR
|
NR
|
NR
|
NR
|
Zhang et al. [23]
|
CN
|
2017
|
RETRO
|
44
|
196
|
70
|
67
|
30.8 (15.4–99.2)
|
99.2 (39.3–205.2)
|
20/22
|
113/83
|
25.5 (23.7–28.7)
|
25.0 (22.3–28.7)
|
15 (I–II)/37 (III–IV)
|
49 (I–II)/130 (III–IV)
|
Xiong et al. [24]
|
CN
|
2013
|
RETRO
|
46
|
32
|
58.2 ± 11.3
|
59.6 ± 11.0
|
254.0 ± 63.5
|
294.2 ± 135.7
|
28/18
|
21/11
|
21.0 ± 2.5
|
20.3±1.9
|
1/14/7/15/9
|
1/8/6/9/8
|
Farges et al. [25]
|
EURO
|
2012
|
RETRO
|
186
|
180
|
62 ± 11
|
61 ± 10
|
126 (17–255)
|
113 (40–274)
|
107/79
|
127/53
|
24 ± 4
|
25 ± 4
|
6/47/267/19/27
|
4/23/137/10/6
|
Wronka et al. [26]
|
Poland
|
2019
|
RETRO
|
23
|
58
|
56 (48–65)
|
60 (55–67)
|
164.8 (18.8–336.4)
|
36.6 (15.9–83.8)
|
13/10
|
34/24
|
NR
|
NR
|
NR
|
NR
|
Ferrero et al. [27]
|
Italy
|
2008
|
RETRO
|
30
|
30
|
63.5 (35–80)
|
66.0 (47–80)
|
210.3 (59.9–533.5)
|
225.7
|
19/11
|
13/17
|
NR
|
NR
|
NR
|
NR
|
Su et al. [28]
|
USA
|
1996
|
RETRO
|
16
|
33
|
NR
|
NR
|
NR
|
NR
|
NR
|
NR
|
NR
|
NR
|
NR
|
NR
|
Li et al. [29]
|
CN
|
2009
|
RETRO
|
56
|
55
|
NR
|
NR
|
268 ± 174
|
256 ± 136
|
NR
|
NR
|
NR
|
NR
|
NR
|
NR
|
Ribero et al. [30]
|
Italy
|
2016
|
RETRO
|
35
|
98
|
67 (35–82)
|
65 (40–84)
|
94.1
|
63.3
|
22/13
|
62/36
|
NR
|
NR
|
0/8/12/13/2
|
0/17/43/27/11
|
Parks et al. [31]
|
UK
|
2000
|
RETRO
|
27
|
20
|
59 ± 3
|
57 ± 2
|
335 (9–670)
|
278 (35–666)
|
20/7
|
16/4
|
NR
|
NR
|
2/7/11/5/2
|
2/2/10/2/4
|
Dinant et al. [32]
|
Netherlands
|
2006
|
RETRO
|
14
|
83
|
NR
|
NR
|
NR
|
NR
|
NR
|
NR
|
NR
|
NR
|
NR
|
NR
|
Hanafy [33]
|
Egypt
|
2010
|
RETRO
|
54
|
46
|
50.4 ± 12
|
53.3±11
|
314.6 ± 205.2
|
92.34 ± 126.5
|
34/20
|
30/16
|
NR
|
NR
|
NR
|
NR
|
Ercolani et al. [34]
|
Japan
|
2010
|
RETRO
|
7
|
44
|
NR
|
NR
|
NR
|
NR
|
NR
|
NR
|
NR
|
NR
|
NR
|
NR
|
Gerhards et al. [35]
|
Netherlands
|
1999
|
RETRO
|
18
|
93
|
NR
|
NR
|
NR
|
NR
|
NR
|
NR
|
NR
|
NR
|
NR
|
NR
|
Chen et al. [36]
|
CN
|
2007
|
RETRO
|
27
|
31
|
NR
|
NR
|
382 ± 174
|
292 ± 103
|
NR
|
NR
|
NR
|
NR
|
2/6/3/7/9
|
1/4/6/12/8
|
- Data shown represents mean ± standard deviation or median (minimum-maximum); Bismuth-classification = I/II/IIIa/IIIb/
- TSB total serum bilirubin, No number, M male, F female, BMI body mass index, PBD preoperative biliary drainage group, NPBD non-preoperative biliary drainage group, Retro retrospective, NR not report